We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 7th:
Corcept Therapeutics Incorporated (CORT - Free Report) : This pharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 38.5% over the last 60 days.
Corcept Therapeutics Incorporated Price and Consensus
Changyou.com Limited : This operator of online gameshas a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.
Gilead Sciences, Inc. (GILD - Free Report) : This healthcare company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 8.5% over the last 60 days.
Beazer Homes USA, Inc. (BZH - Free Report) : This homebuilding company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.2% over the last 60 days.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade, which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Ranked Momentum Stocks to Buy for August 7th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 7th:
Corcept Therapeutics Incorporated (CORT - Free Report) : This pharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 38.5% over the last 60 days.
Corcept Therapeutics Incorporated Price and Consensus
Corcept Therapeutics Incorporated Price and Consensus | Corcept Therapeutics Incorporated Quote
Corcept Therapeutics' shares gained 20.5% over the last one month higher than S&P 500’s gains of 2.8%. The company possesses a Momentum Score of A.
Corcept Therapeutics Incorporated Price
Corcept Therapeutics Incorporated Price | Corcept Therapeutics Incorporated Quote
Changyou.com Limited : This operator of online gameshas a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.
Changyou.com Limited Price and Consensus
Changyou.com Limited Price and Consensus | Changyou.com Limited Quote
Changyou.com 's shares gained 13.2% over the last one month. The company possesses a Momentum Score of A.
Changyou.com Limited Price
Changyou.com Limited Price | Changyou.com Limited Quote
Gilead Sciences, Inc. (GILD - Free Report) : This healthcare company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 8.5% over the last 60 days.
Gilead Sciences, Inc. Price and Consensus
Gilead Sciences, Inc. Price and Consensus | Gilead Sciences, Inc. Quote
Gilead Sciences' shares gained 5.3% over the last one month. The company possesses a Momentum Score of A.
Gilead Sciences, Inc. Price
Gilead Sciences, Inc. Price | Gilead Sciences, Inc. Quote
Beazer Homes USA, Inc. (BZH - Free Report) : This homebuilding company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.2% over the last 60 days.
Beazer Homes USA, Inc. Price and Consensus
Beazer Homes USA, Inc. Price and Consensus | Beazer Homes USA, Inc. Quote
Beazer Homes USA's shares gained 16.7% over the last one month. The company possesses a Momentum Score of A.
Beazer Homes USA, Inc. Price
Beazer Homes USA, Inc. Price | Beazer Homes USA, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade, which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>